New Fortress Energy
NFE
Lantheus
LNTH
Dorian LPG
LPG
eBay
EBAY
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 1.110
- +0.060+5.71%
Close Mar 4 16:00 ET
- 1.110
- 0.0000.00%
Post 20:01 ET
9.34MMarket Cap-0.06P/E (TTM)
1.140High0.980Low694.18KVolume1.020Open1.050Pre Close728.07KTurnover13.27%Turnover RatioLossP/E (Static)8.41MShares122.01852wk High-2.04P/B5.81MFloat Cap0.57552wk Low--Dividend TTM5.23MShs Float122.013Historical High--Div YieldTTM15.24%Amplitude0.575Historical Low1.048Avg Price1Lot Size
About Silexion Therapeutics Company
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.
Company Profile
SymbolSLXN
Company NameSilexion Therapeutics
Listing DateApr 9, 2021
CEOMr. Ilan Hadar
MarketNASDAQ
Address12 Abba Hillel Road
CityRamat-Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250606
Phone972-8-628-6005
Websitehttps://www.silexion.com
Company Executives
- Name
- Position
- Salary
- Ilan Hadar
- Chairman of the Board and Prospective Chief Executive Officer
- 253.61K
- Mirit Horenshtein Hadar
- Executive Vice President, Finance Affairs and Prospective Chief Financial Officer
- 26.24K
- Dr. Mitchell Shirvan
- Chief Scientific and Development Officer
- 206.80K
- Dror J. Abramov
- Independent Director
- --
- Avner Lushi
- Independent Director
- --
- Ruth Alon
- Independent Director
- --
- Ilan Levin
- Independent Director
- --
- Professor Amnon Peled, PhD
- Independent Director
- --
- Shlomo Noy
- Independent Director
- --